Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Biomarkers in multiple sclerosis (a review and experimental data)].
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
[Multiple sclerosis].
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Experimental Autoimmune Encephalomyelitis in Marmosets.
Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).
Reduced Myelin Water in the White Matter Tracts of Patients with Niemann-Pick Disease Type C.
Tumefactive multiple sclerosis in taiwan.
Cross-validation of oxygen uptake prediction during walking in ambulatory persons with multiple sclerosis.
Cell-Based Reparative Therapies for Multiple Sclerosis.
Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic.
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)].
Heart rate variability.
A 62-year-old man with fluctuating neurological deficits and skin lesions.
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.
Altered Effective Connectivity during a Processing Speed Task in Individuals with Multiple Sclerosis.
Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Voxel-Wise Displacement as Independent Features in Classification of Multiple Sclerosis.
Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.
Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis.
Pages
« first
‹ previous
…
490
491
492
493
494
495
496
497
498
…
next ›
last »